Sandy W. Wong

3.3k total citations
86 papers, 1.1k citations indexed

About

Sandy W. Wong is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Sandy W. Wong has authored 86 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 47 papers in Hematology and 37 papers in Molecular Biology. Recurrent topics in Sandy W. Wong's work include Multiple Myeloma Research and Treatments (44 papers), CAR-T cell therapy research (30 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (16 papers). Sandy W. Wong is often cited by papers focused on Multiple Myeloma Research and Treatments (44 papers), CAR-T cell therapy research (30 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (16 papers). Sandy W. Wong collaborates with scholars based in United States, Spain and France. Sandy W. Wong's co-authors include Nina Shah, Jeffrey L. Wolf, Chiung‐Yu Huang, Raymond L. Comenzo, Thomas Martin, Luciano J. Costa, Vanessa E. Kennedy, William Bensinger, Swetha Kambhampati and Mimi Lo and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Sandy W. Wong

82 papers receiving 1.1k citations

Peers

Sandy W. Wong
Caitlin Costello United States
Thomas G. Martin United States
Éric Charpentier United States
Marc‐Steffen Raab Germany
Thomas Köhnke Germany
Kelly McGlinchey United States
Jakub Krejcik Denmark
Brandi Hilder United States
Jaime Bald United States
Pei Lin United States
Caitlin Costello United States
Sandy W. Wong
Citations per year, relative to Sandy W. Wong Sandy W. Wong (= 1×) peers Caitlin Costello

Countries citing papers authored by Sandy W. Wong

Since Specialization
Citations

This map shows the geographic impact of Sandy W. Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandy W. Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandy W. Wong more than expected).

Fields of papers citing papers by Sandy W. Wong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandy W. Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandy W. Wong. The network helps show where Sandy W. Wong may publish in the future.

Co-authorship network of co-authors of Sandy W. Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Sandy W. Wong. A scholar is included among the top collaborators of Sandy W. Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandy W. Wong. Sandy W. Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ledergor, Guy, Kaichun Wu, Elizabeth McCarthy, et al.. (2024). CD4+ CAR T-cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR T-cell therapy. Blood Advances. 8(13). 3562–3575. 19 indexed citations
2.
Reyes, Kevin, Yen‐Chun Liu, Chiung‐Yu Huang, et al.. (2024). Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma. Blood Advances. 8(9). 2207–2216. 15 indexed citations
3.
Ailawadhi, Sikander, Leyla Shune, Sandy W. Wong, et al.. (2024). Optimizing the CAR T-Cell Therapy Experience in Multiple Myeloma: Clinical Pearls From an Expert Roundtable. Clinical Lymphoma Myeloma & Leukemia. 24(5). e217–e225. 8 indexed citations
4.
Kennedy, Vanessa E., Nina Shah, Shagun Arora, et al.. (2023). Daratumumab Plus Bortezomib and Dexamethasone in Newly Diagnosed Systemic Light Chain Amyloidosis. Current Problems in Cancer. 47(3). 100953–100953. 4 indexed citations
5.
Reyes, Kevin, Chiung‐Yu Huang, Mimi Lo, et al.. (2023). Safety and Efficacy of BCMA CAR-T Cell Therapy in Older Patients With Multiple Myeloma. Transplantation and Cellular Therapy. 29(6). 350–355. 26 indexed citations
6.
Wong, Sandy W., Habib Hamidi, Luciano J. Costa, et al.. (2023). Multi-omic analysis of the tumor microenvironment shows clinical correlations in Ph1 study of atezolizumab +/- SoC in MM. Frontiers in Immunology. 14. 1085893–1085893. 3 indexed citations
7.
Benjamin, D. M., Spencer Phillips Hey, Amanda MacPherson, et al.. (2022). Principal investigators over-optimistically forecast scientific and operational outcomes for clinical trials. PLoS ONE. 17(2). e0262862–e0262862. 6 indexed citations
8.
Kambhampati, Swetha, Ying Sheng, Chiung‐Yu Huang, et al.. (2021). Infectious complications in patients with relapsed refractory multiple myeloma after BCMA CAR T-cell therapy. Blood Advances. 6(7). 2045–2054. 79 indexed citations
9.
Lentzsch, Suzanne, Samuel Pan, Divaya Bhutani, et al.. (2021). Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis. Blood Cancer Journal. 11(1). 10–10. 70 indexed citations
10.
Banerjee, Rahul, Chiung‐Yu Huang, Mimi Lo, et al.. (2021). Early Time-to-Tocilizumab after B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy in Myeloma. Transplantation and Cellular Therapy. 27(6). 477.e1–477.e7. 27 indexed citations
11.
Kambhampati, Swetha, Bita Fakhri, Ying Sheng, et al.. (2020). Infectious Complications of BCMA-Targeted and CD19-Targeted Chimeric Antigen Receptor T-Cell Immunotherapy. Blood. 136(Supplement 1). 4–5. 10 indexed citations
12.
Alonso, Rafael, María‐Teresa Cedena, Sandy W. Wong, et al.. (2020). Prolonged lenalidomide maintenance therapy improves the depth of response in multiple myeloma. Blood Advances. 4(10). 2163–2171. 27 indexed citations
13.
Tian, Ruilin, Priya Choudhry, Torsten Hechler, et al.. (2020). CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma. Blood Advances. 4(13). 2899–2911. 37 indexed citations
14.
Wong, Sandy W., et al.. (2020). Supportive Care for Patients with Systemic Light Chain Amyloidosis. Hematology/Oncology Clinics of North America. 34(6). 1177–1191. 3 indexed citations
15.
Cedena, María‐Teresa, Sandy W. Wong, Nina Shah, et al.. (2020). The clinical significance of stringent complete response in multiple myeloma is surpassed by minimal residual disease measurements. PLoS ONE. 15(8). e0237155–e0237155. 19 indexed citations
16.
17.
Huang, Li‐Wen, Sandy W. Wong, Charalambos Andreadis, & Rebecca L. Olin. (2019). Updates on Hematologic Malignancies in the Older Adult: Focus on Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma. Current Oncology Reports. 21(4). 35–35. 2 indexed citations
18.
Tan, Marisela, Evan Kalin-Hajdu, Rupa Narayan, Sandy W. Wong, & Thomas Martin. (2018). Zoledronic acid-induced orbital inflammation in a patient with multiple myeloma. Journal of Oncology Pharmacy Practice. 25(5). 1253–1257. 4 indexed citations
19.
Ferguson, Ian, Megan Murnane, Hui Liu, et al.. (2018). Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment. Haematologica. 103(7). 1218–1228. 27 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caitlin Costello Breakdown of academic impact, for papers by Thomas G. Martin Breakdown of academic impact, for papers by Éric Charpentier Breakdown of academic impact, for papers by Marc‐Steffen Raab Breakdown of academic impact, for papers by Thomas Köhnke Breakdown of academic impact, for papers by Kelly McGlinchey Breakdown of academic impact, for papers by Jakub Krejcik Breakdown of academic impact, for papers by Brandi Hilder Breakdown of academic impact, for papers by Jaime Bald Breakdown of academic impact, for papers by Pei Lin
Rankless by CCL
2026